Treatment of hepatitis C in patients with thalassemia

Free article

Editorial

Emanuele Angelucci et al. Haematologica. 2008 Aug.

Free article

. 2008 Aug;93(8):1121-3.

doi: 10.3324/haematol.13500.

No abstract available

Comment on

Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Di Marco V, Capra M, Gagliardotto F, Borsellino Z, Cabibi D, Barbaria F, Ferraro D, Cuccia L, Ruffo GB, Bronte F, Di Stefano R, Almasio PL, Craxì A. Di Marco V, et al. Haematologica. 2008 Aug;93(8):1243-6. doi: 10.3324/haematol.12554. Epub 2008 Jun 12. Haematologica. 2008. PMID: 18556410
Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia.
Harmatz P, Jonas MM, Kwiatkowski JL, Wright EC, Fischer R, Vichinsky E, Giardina PJ, Neufeld EJ, Porter J, Olivieri N; Thalassemia Clinical Research Network. Harmatz P, et al. Haematologica. 2008 Aug;93(8):1247-51. doi: 10.3324/haematol.12352. Epub 2008 Jun 12. Haematologica. 2008. PMID: 18556414 Clinical Trial.